These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2082958)

  • 21. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological and clinical effects of interferon-beta ser at two doses.
    Borden EC; Rinehart JJ; Storer BE; Trump DL; Paulnock DM; Teitelbaum AP
    J Interferon Res; 1990 Dec; 10(6):559-70. PubMed ID: 2086672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of recombinant beta-interferon given by four-hour infusion.
    Grunberg SM; Kempf RA; Venturi CL; Mitchell MS
    Cancer Res; 1987 Feb; 47(4):1174-8. PubMed ID: 3802098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma.
    Coates A; Rallings M; Hersey P; Swanson C
    J Interferon Res; 1986 Feb; 6(1):1-4. PubMed ID: 2871116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon beta for multiple sclerosis.
    Connelly JF
    Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth of astrocytomas in the human tumor clonogenic assay and sensitivity to mismatched dsRNA and interferons.
    Strayer DR; Weisband J; Carter WA; Black P; Nidzgorski F; Cook AW
    Am J Clin Oncol; 1987 Aug; 10(4):281-4. PubMed ID: 3039828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
    Sperber SJ; Levine PA; Sorrentino JV; Riker DK; Hayden FG
    J Infect Dis; 1989 Oct; 160(4):700-5. PubMed ID: 2551976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal interferon-beta: sustained release treatment of simian varicella virus infection in monkeys.
    Eppstein DA; Van der Pas MA; Gloff CA; Soike KF
    J Infect Dis; 1989 Apr; 159(4):616-20. PubMed ID: 2538517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
    Dutcher JP; Salva KM; Wiernik PH
    Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and adverse effects of beta-interferon in the treatment of malignant glioma].
    Oda Y; Konishi T; Suzui H; Kamijo Y; Kang Y; Okumura T; Kaneko T; Kikuchi H
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2411-7. PubMed ID: 2614179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunobiology of primary intracranial tumors: IX. Phase I study of human lymphoblastoid interferon.
    Mahaley MS; Urso MB; Whaley RA; Staab EV; Williams TE; Guaspari A
    J Biol Response Mod; 1984; 3(1):19-25. PubMed ID: 6707697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
    Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
    J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.
    Chiang J; Gloff CA; Yoshizawa CN; Williams GJ
    Pharm Res; 1993 Apr; 10(4):567-72. PubMed ID: 8483840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.
    Jones GJ; Itri LM
    Cancer; 1986 Apr; 57(8 Suppl):1709-15. PubMed ID: 3948143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.
    Wadler S; Haynes H; Rozenblit A; Hu X; Kaleya R; Wiernik PH
    Cancer J Sci Am; 1998; 4(5):331-7. PubMed ID: 9815298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma.
    Buzaid AC; Robertone A; Kisala C; Salmon SE
    J Clin Oncol; 1987 Jul; 5(7):1083-9. PubMed ID: 3598612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I study of recombinant human interferon beta in patients with advanced cancer.
    Hu E; Horning SJ
    J Biol Response Mod; 1987 Apr; 6(2):121-9. PubMed ID: 3585409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study.
    Krigel RL; Padavic-Shaller KA; Rudolph AR; Poiesz BJ; Comis RL
    J Biol Response Mod; 1989 Aug; 8(4):359-65. PubMed ID: 2666585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.